CV Therapeutics INC
SEC CIK 921506 · CVTX · last insider filing 2009-04-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lange Louis G | Director · Chairman & CEO | filed 2006 - 2009 |
| Costa Santo J | Director | filed 2006 - 2009 |
| Gutshall Thomas L | Director | filed 2006 - 2009 |
| Shenk Thomas E | Director | filed 2006 - 2009 |
| LEE Kenneth B JR | Director | filed 2006 - 2009 |
| Davie Joseph MD PHD | Director | filed 2006 - 2009 |
| Hutt Peter Barton | Director | filed 2006 - 2007 |
| Mcneil Barbara J | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Blackburn Brent K | SVP, Drug Discovery & Dev | filed 2006 - 2009 |
| Spiegelman Daniel K | SVP, CFO | filed 2006 - 2009 |
| Suvari Tricia Borga | VP, Gen Counsel, Asst Sec | filed 2006 - 2009 |
| Stuart Lewis J | SVP COMMERCIAL OPERATIONS | filed 2007 - 2009 |
| Mccaleb David C | SVP Commercial Operations | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.